Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05913531
Other study ID # Retro-Delirium
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 23, 2023
Est. completion date December 31, 2026

Study information

Verified date July 2023
Source Charite University, Berlin, Germany
Contact Claudia Spies, MD Prof.
Phone +49 30 450 55 11 02
Email claudia.spies@charite.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluation of several studies of the Clinic for Anesthesiology and Intensive Care Medicine CCM/CVK/CBF to create a register with the delirium data from anesthesiology study patients between 18 - 100 years. The primary purpose of the register is to assess factors influencing the development of delirium. In a subproject, risk factors that may lead to the development of postoperative delirium in the elderly will be evaluated with regard to gender differences using patients from the age of 60 with different surgical procedures. The risk factors examined are based on the evidence-based and consensus-based recommendations of the ESA guideline and literature review. In addition, the delirium incidence rate and the delirium severity is examined regarding gender differences.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date December 31, 2026
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Male and female patients age = 18 years of studies of the clinic for Anesthesiology and Intensive Care Medicine CCM/CVK/CBF Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Department of Anaesthesiolgy and Intensive Care Medicine CVK/CCM, Charité - Univeristy Medicine Berlin Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Parameter of cognition Cognitive functioning will be measured with a battery of computerized neuropsychological tests. Up to 5 years
Other Parameter of cognition Cognitive functioning will be measured with a battery of non-computerized neuropsychological tests. Up to 5 years
Other Demographic data Demographic data are documented in the hospital records. Up to 5 years
Primary Delirium Validated delirium scoring (points, duration and severity) Up to 5 years
Secondary Sedation scales Sedation is measured by the Richmond Agitation Sedation Scale Up to 5 years
Secondary Socioeconomic information 1 Soci-economic information is collected by FIMA Up to 5 years
Secondary Socioeconomic information 2 Soci-economic information is collected by the Nikolaus-score (social situation), 1. Subscale Up to 5 years
Secondary Socioeconomic information 3 Soci-economic information is collected by items on socioeconomic status from the Federal Health Survey of 1998 Up to 5 years
Secondary Comorbidities Comorbidities are new diagnoses from hospital records. Up to 5 years
Secondary Charlson comorbidity index Comorbidity scores Up to 5 years
Secondary Lifestyle risks 1 Consumption of alcohol is measured by AUDIT (Alcohol Use Disorders Identification Tests) Up to 5 years
Secondary Lifestyle risks 2 Consumption of and nicotine is measured by Fagerström Test for Cigarette Dependence (FTCD). Questionnaire scored 0-10 points with Total Score equal to the sum of all points Up to 5 years
Secondary Lifestyle risks 3 Consumption of nicotine is measured by Smocking Pack Years (SPY) Up to 5 years
Secondary Lifestyle risks 4 Previous consumption of nicotine is measured by History of Smoking. Up to 5 years
Secondary Level of education Level of education is measured by ISCED (International Standard Classification of Education) Up to 5 years
Secondary Quality of life - relatives Quality of life is measured by CarerQoL Up to 5 years
Secondary Quality of life - self 1 Quality of life is measured by EQ-5D.An index calculated from the five EQ-5D (3L and 5L) dimensions by attaching specific weights to each severity level in each dimension. Up to 5 years
Secondary Quality of life - self 2 Quality of life is measured by WHO-5. WHO-5 is a short and generic global rating scale measuring subjective well-being, the respondent is asked to rate how well each of the 5 statements applies to him or her when considering the last 14 days. Each of the 5 items is scored from 5 (all of the time) to 0 (none of the time). The raw score ranges from 0 (absence of well-being) to 25 (maximal well-being). Scores are then converted to a percentage scale from 0 (absent) to 100 (maximal). Higher scores represent greater psychological well-being. Up to 5 years
Secondary Quality of life - self 3 Quality of life is measured by SF-12 (Short form health survey) Up to 5 years
Secondary Functional impairment (IADL) 1 Instrumental Activities of Daily Living (IADLs) < 8 Up to 5 years
Secondary Functional impairment (ADL) 2 Activities of Daily Living (ADLs) < 100 Up to 5 years
Secondary Depression 1 Depression 1 is measured by PHQ-8 (Patient Health Questionnaire depression scale) Up to 5 years
Secondary Depression 2 Depression 2 is measured by GDS (Geriatric Depression Scale) Up to 5 years
Secondary Depression 3 Depression 3 is measured by HADS (Hospital Anxiety and Depression Scale) Up to 5 years
Secondary Depression 4 Depression 4 is measured by CDS (Cornel Depression Scale) Up to 5 years
Secondary Anxiety scales 1 Anxiety is measured by GAD-7 (Generalized Anxiety Disorder 7) Up to 5 years
Secondary Anxiety scale 2 Anxiety 2 is measured by FAS (Faces Anxiety Scale) Up to 5 years
Secondary Anxiety scale 2 Anxiety 2 is measured by GAD-7 Up to 5 years
Secondary Pain Pain is measured by numeric pain scales (minimum = 0, maximum = 10). Up to 5 years
Secondary Type of concomitant medication The medication administered during the hospital stay is documented. Up to 5 years
Secondary Anticholinergic Load Measured by anticholinergic drug scale Up to 5 years
Secondary Frailty Frailty is measured with a modified frailty score according to Fried´s frailty phenotype assessment. Up to 5 years
Secondary Nutritional status 1 Nutritional status 1 is measured by calf circumference Up to 5 years
Secondary Nutritional status 2 Nutritional status 2 is measured by arm circumference Up to 5 years
Secondary Nutritional status 3 Nutritional status 3 is measured by changes in weight Up to 5 years
Secondary Nutritional status 4 Nutritional status 4 is measured by changes in body mass index Up to 5 years
Secondary Nutritional status 5 Nutritional status 5 is measured by previous weight history (3 months) Up to 5 years
Secondary Nutritional status 6 Nutritional status 6 is measured by Medi-Score Up to 5 years
Secondary Nutritional status 7 Nutritional status 7 is measured by MNA-SF Up to 5 years
Secondary Nutritional status 8 Nutritional status 8 is measured by Sarcopenia Up to 5 years
Secondary Nutritional status 9 Nutritional status 9 is measured by Nutritional Risk Screening (NRS 2002) Up to 5 years
Secondary Nutritional status 10 Nutritional status 10 is measured by AKE Screening Up to 5 years
Secondary Mobility 1 Mobility 1 is measured with the Timed up and Go Up to 5 years
Secondary Mobility 2 Mobility 2 is measured with a walking test: Slowness: Calculated after walking 3 meters, adjusted for sex and height, according to Fried. The cut-off points for 3 meters were established as, in men: height =173 cm and time =4.59 s (equivalent to 0.65 m/s); height >1.73 cm and time =3.93 s (equivalent to 0.76 m/s); and for women: height =1.59 cm and time =4.59 s (0.65 m/s); and height >1.59 cm and time =3.93 s (0.76 m/s). Up to 5 years
Secondary Number of participants with changes in laboratory values 1 Laboratory results in the hospital including hemoglobin, lymphocytes, total neutrophils, platelet count, white blood cell (WBC) count and inflammatory markers from blood samples. Up to 5 years
Secondary Number of participants with changes in laboratory values 2 Laboratory results in the hospital from serum samples Up to 5 years
Secondary Number of participants with changes in laboratory values 3 Laboratory results in the hospital from urine samples Up to 5 years
Secondary Number of participants with changes in laboratory values 4 Laboratory results in the hospital from liquor samples Up to 5 years
Secondary Depth of sedation The sedation was measured intraoperatively processed electroencephalogram (EEG) Full-brain EEG recording with surface electrodes, raw EEG analysis measured during the operation. Up to 5 years
Secondary Type of operation Type of operation is measured by OPS-Code Up to 5 years
Secondary Duration of operation Type of operation is measured in minutes Up to 5 years
Secondary Type of anesthesia There are four main categories of anesthesia used during surgery and other procedures: general anesthesia, regional anesthesia, sedation (sometimes called "monitored anesthesia care"), and local anesthesia. Up to 5 years
Secondary Duration of anesthesia Duration of anesthesia is measured in minutes. Up to 5 years
Secondary Length of hospital stay Hospital stay is measured in days. Up to 5 years
Secondary Intensive care unit stay Intensive care unit stay is measured in hours. Up to 5 years
Secondary Organ complications Organ complications are recorded in hospital records Up to 5 years
Secondary Hospital discharge criteria Discharge criteria are measured at hospital discharge by Post Anesthetic Discharge Scoring System (PADS) Score Up to 5 years
Secondary Mortality Mortality rate is measured after 1,2,3,4 and 5 years Up to 5 years
Secondary Study data Identification of study data with a high impact on delirium from the study databases Up to 5 years
Secondary Sleeping items Questions measuring personal satisfaction with sleep quality and duration As measured by questions measuring personal satisfaction with sleep quality and duration Up to 5 years
Secondary Circadian rhythm variables Items measuring circadian rhythm variables e.g. Zeitgebers Up to 5 years
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A